ROYAL LONDON ASSET MANAGEMENT LTD
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 863748
UNITED KINGDOM, X0
Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$64,296,696
-$6,865,169 QoQ
Shares Held
213,589
-0.7% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#71
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $597,315,774 across 9 Biotechnology names. ALNY ranks #4 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
4,319,595 | $242,199,691 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,810,815 | $141,732,490 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
241,280 | $119,851,014 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
213,589 | $64,296,696 | |
| 5 | INCY |
Incyte Corp
|
190,323 | $21,575,015 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,887 | $2,423,699 | |
| 7 | INSM |
INSMED Inc
|
22,116 | $2,358,007 | |
| 8 | LEGN |
Legend Biotech Corp
|
75,000 | $2,166,000 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,296,696 | 213,589 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $71,161,865 | 215,075 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $100,634,080 | 253,072 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $117,334,728 | 257,313 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $84,480,462 | 259,071 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $77,480,348 | 286,943 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $66,241,882 | 281,509 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $76,939,642 | 279,750 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $68,609,835 | 282,345 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $48,850,572 | 326,869 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $59,112,001 | 308,824 | Shares | Sole | 2024-03-01 | |
| 2023-09-30 | $54,297,974 | 306,595 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $31,195,365 | 164,238 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $24,994,126 | 124,771 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,999,836 | 42,078 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $8,134,902 | 40,642 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,185,644 | 42,411 | Shares | Sole | 2022-09-06 | |
| 2022-03-31 | $6,786,332 | 41,560 | Shares | Sole | 2022-09-06 | |
| 2021-12-31 | $6,834,582 | 40,303 | Shares | Sole | 2022-10-18 | |
| 2021-09-30 | $7,794,076 | 41,280 | Shares | Sole | 2022-10-18 | |
| 2021-06-30 | $7,186,291 | 42,392 | Shares | Sole | 2022-10-18 | |
| 2021-03-31 | $5,985,326 | 42,392 | Shares | Sole | 2022-10-17 | |
| 2020-12-31 | $5,411,430 | 41,636 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $6,214,644 | 42,683 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $6,029,261 | 40,708 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $4,431,065 | 40,708 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||